Your session is about to expire
← Back to Search
Exercise Training for Mild Cognitive Impairment
N/A
Waitlist Available
Led By Ging-Yuek Robin Hsiung, MD, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a baseline Montreal Cognitive Assessment (MoCA) score < 26/30
Able to walk independently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 12 months, and 18 months
Awards & highlights
Study Summary
This trial will test the effects of AT, RT, and a combination of both on cognitive function in older adults with mild cognitive impairment.
Who is the study for?
This trial is for older adults in Metro Vancouver with mild cognitive impairment, who have a MMSE score of 22 or higher and MoCA score below 26. They should be able to walk, follow the trial's plan, and not be on certain dementia medications. People already doing moderate exercise, diagnosed with dementia other than AD or VCI, at high cardiac risk during exercise, or on cognition-impairing drugs can't join.Check my eligibility
What is being tested?
The study tests how different types of exercises affect brain function in those with mild cognitive impairment. It compares aerobic training (like running), resistance training (like lifting weights), and balance/tone training to see which is best for improving memory and thinking skills.See study design
What are the potential side effects?
Exercise programs generally carry risks like muscle strain or injury from physical activity. Specific side effects will depend on the individual's health condition but are typically low when exercises are done correctly under supervision.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My cognitive test score is below 26 out of 30.
Select...
I can walk on my own without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months, 12 months, and 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 12 months, and 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cognitive function as measured by Alzheimer's Disease Assessment Scale Cognitive Subscale Plus (ADAS-Plus)
Secondary outcome measures
ADAS-Cog Plus
Body composition as measured by DXA
Brain function as measured by functional magnetic resonance imaging (fMRI)
+47 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Resistance Training (RT)Experimental Treatment2 Interventions
The RT program will be a four-times-per week program. Twice a week will be resistance training in which a pressurized air system and free weights will be used to provide the training stimulus. Other key strength exercises (with free weights) will include mini-squats, mini-lunges, and lunge walks. The intensity of the training stimulus will initially be at 50% to 60% of 1 repetition maximum (RM) as determined at week two, and progress to 75% to 85% of 1-RM at a work level of 6 to 8 repetitions (2 sets) by week four. The training stimulus will be increased using the 7 RM method, when 2 sets of 6-8 repetitions are completed with proper form. The other two days per week are a balance and tone program consisting of stretching exercises, basic core-strength/kegal exercises, and relaxation techniques. Other than bodyweight, no additional loading (e.g., hand weights, resistance bands, etc.) will be applied to any of the exercises.
Group II: Aerobic Training and Resistance Training (A&RT)Experimental Treatment2 Interventions
The A&RT program will be a four-times-per week program. Twice a week will be aerobic training consisting of outdoor walks with certified fitness instructors. The outdoor walking program will start participants out working at 45% of their heart rate reserve, and work up to 70% of the heart rate reserve. The other two days a week will be resistance training in which a pressurized air system and free weights will be used to provide the training stimulus. Other key strength exercises (with free weights) will include mini-squats, mini-lunges, and lunge walks. The intensity of the training stimulus will initially be at 50% to 60% of 1 repetition maximum (RM) as determined at week two, and progress to 75% to 85% of 1-RM at a work level of 6 to 8 repetitions (2 sets) by week four. The training stimulus will be increased using the 7 RM method, when 2 sets of 6-8 repetitions are completed with proper form.
Group III: Aerobic Training (AT)Experimental Treatment2 Interventions
The AT program will be a four-times-per week program. Twice a week will be aerobic training consisting of outdoor walks with certified fitness instructors. The outdoor walking program will start participants out working at 45% of their heart rate reserve, and work up to 70% of the heart rate reserve. The other two days per week are a balance and tone program consisting of stretching exercises, basic core-strength/kegal exercises, and relaxation techniques. Other than bodyweight, no additional loading (e.g., hand weights, resistance bands, etc.) will be applied to any of the exercises.
Group IV: Balance and Tone Program (CON)Active Control1 Intervention
The CON program will be a four-times-per week program. The CON group will consist of stretching exercises, basic core-strength/kegal exercises, and relaxation techniques. Other than bodyweight, no additional loading (e.g., hand weights, resistance bands, etc.) will be applied to any of the exercises.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic Training
2020
N/A
~830
Resistance Training
2019
Completed Phase 2
~1190
Balance and Tone Training
2017
N/A
~30
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,333 Total Patients Enrolled
Ging-Yuek Robin Hsiung, MD, PhDPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
91 Total Patients Enrolled
Alexander MacKay, PhDPrincipal InvestigatorUniversity of British Columbia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have nerve damage or severe joint issues that affect my ability to move.My cognitive test score is below 26 out of 30.I can walk on my own without help.I have been diagnosed with a type of dementia.I am at high risk for heart problems during exercise or can't manage my activity level.I am suspected to have a brain condition causing memory issues, not due to Alzheimer's or blood flow problems.I am not on medications that could worsen my thinking or memory.I am not planning to change my dementia medication dose for the next 6 months.I have not taken hormone therapy in the last 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: Aerobic Training and Resistance Training (A&RT)
- Group 2: Resistance Training (RT)
- Group 3: Aerobic Training (AT)
- Group 4: Balance and Tone Program (CON)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger